Gerry Brunk is listed as a director on 18 SEC Form D filings by 5 issuers between Mar 2013 and Oct 2024: HistoSonics, Inc. (Plymouth, MN — other health care — 2019–2024; $102M reported sold to 44 investors), ENDOTRONIX INC (Lisle, IL — other health care — 2016–2020; $69.3M reported sold to 52 investors), SpectraWAVE, Inc. (Bedford, MA — industry reported as "Other" — 2024; $50.3M reported sold to 33 investors), Corvia Medical, Inc. (Tewksbury, MA — biotechnology — 2013–2021; $34M reported sold to 25 investors) and Engage Therapeutics, Inc. (Summit, NJ — pharmaceuticals — 2017–2019; $23.6M reported sold to 18 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $279.2M sold in total.
Listed alongside Paul LaViolette (11 shared filings), Fred Lee (5 shared filings), Harry Rowland (5 shared filings), James J. Hummer (5 shared filings), Kadir Kadhiresan (5 shared filings) and 36 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gerry. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 18 public filings for Gerry Brunk and found 10 differences: 4 offerings changed their target amount between filings; 4 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.